BlackRock Updates Passive Stake in Moderna (MRNA) via SC 13G/A
Ticker: MRNA · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1682852
| Field | Detail |
|---|---|
| Company | Moderna, Inc. (MRNA) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investing, amendment, biotech
Related Tickers: MRNA
TL;DR
**BlackRock just updated its Moderna stake, watch for market reaction.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Moderna, Inc. common stock as of December 31, 2023. This filing, an amendment number 2, shows BlackRock's updated passive stake in Moderna. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal its confidence (or lack thereof) in Moderna's future prospects, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's updated ownership in Moderna, providing transparency on a significant institutional investor's position, which can influence market sentiment.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not inherently signal high risk for the stock.
Analyst Insight
Investors should note BlackRock's continued passive stake in Moderna, but this filing alone doesn't provide enough detail to warrant immediate action. It's a routine disclosure of a large institutional holding.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Moderna, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A amendment
- 60770K107 (other) — the CUSIP number for Moderna's Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 2' in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as stated under the 'FILED BY' section and 'Names of reporting person' on the cover page.
What is the subject company of this filing?
The subject company is Moderna, Inc., as identified under 'SUBJECT COMPANY' and 'Name of Issuer' in the filing.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of Moderna, Inc. is 60770K107, as listed in the filing.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified in the 'Date of Event Which Requires Filing of this Statement' section.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding Moderna, Inc. (MRNA).